What Is GLP-1? How GLP-1 Medications Work in the Body
Medical disclaimer: This article is for general education only. It is not medical advice and is not a substitute for care from your healthcare provider. GLP-1 medications are prescription medications. Your prescriber should guide decisions about whether they are right for you, which medication you use, your dose, side effects, and any changes to your treatment plan.
If you are new to GLP-1 medication, you may have noticed that your body is responding in ways you did not expect.
Maybe meals fill you up faster than they used to. Maybe the constant mental chatter about food feels quieter. Maybe foods that used to feel easy now sit differently in your stomach.
That can feel confusing, especially in the beginning. But a lot of these changes connect back to one thing: GLP-1.
Understanding what GLP-1 is, and what GLP-1 medications are designed to do, can make the early part of the journey feel less random and easier to navigate.
What does GLP-1 mean?
GLP-1 stands for glucagon-like peptide-1.
It sounds complicated, but the basic idea is simple: GLP-1 is a hormone your body already makes. It is released by cells in your gut after you eat and helps your body respond to food.
GLP-1 is part of a larger system that helps manage appetite, digestion, insulin, glucagon, and blood sugar after meals. Researchers have studied GLP-1 for decades because it plays an important role in how the body handles food and energy.
What does GLP-1 do in the body?
After you eat, GLP-1 sends signals to different parts of the body. Those signals help explain why GLP-1 medications can affect appetite, fullness, digestion, and blood sugar.
Here are the main things GLP-1 does.
GLP-1 helps the pancreas release insulin when blood sugar is elevated
Insulin is a hormone that helps move sugar from the bloodstream into cells, where it can be used for energy.
GLP-1 helps stimulate insulin release after meals, especially when blood sugar is elevated. This is one reason GLP-1 is called an incretin hormone. Incretin hormones help the body respond to food by supporting insulin release after eating.
This does not mean GLP-1 works the same way for every person or that it replaces individualized medical care. It simply helps explain why GLP-1 medications are often used in people with type 2 diabetes and why they can affect blood sugar regulation.
GLP-1 helps reduce glucagon after meals
Glucagon is another hormone made by the pancreas. Its job is different from insulin. Glucagon tells the liver to release stored sugar into the bloodstream.
After meals, GLP-1 helps reduce glucagon release. More insulin activity and less glucagon activity can help support steadier blood sugar after eating.
GLP-1 slows how quickly the stomach empties
GLP-1 also affects digestion. One of its best-known effects is slowing gastric emptying, which means food moves from the stomach into the small intestine more slowly.
This can help explain a few common early experiences on GLP-1 medication:
- You may feel full sooner.
- You may stay full longer.
- A smaller meal may feel more satisfying than it used to.
- Richer, greasy, or larger meals may feel harder to tolerate.
- Your usual portion sizes may no longer feel right.
This does not mean something is wrong. It may mean your digestion is responding differently than it did before. Still, nausea, vomiting, severe constipation, dehydration, abdominal pain, or symptoms that feel concerning should always be discussed with your healthcare provider.
GLP-1 sends fullness signals to the brain
GLP-1 also interacts with areas of the brain involved in appetite and fullness.
This is one reason people taking GLP-1 medications often describe a shift in hunger. Some people notice they think about food less often. Some describe feeling satisfied earlier in a meal. Others say the constant planning, craving, or mental noise around food feels quieter.
Many people call this change a reduction in “food noise.”
Food noise is not a medical diagnosis. It is a common way people describe repeated or intrusive thoughts about food, hunger, cravings, or what to eat next. For some people, GLP-1 medications can make that mental chatter feel less intense.
So what is a GLP-1 medication?
A GLP-1 medication is designed to activate GLP-1 receptors in the body.
These medications are often called GLP-1 receptor agonists. “Agonist” means the medication activates a receptor. In this case, the medication activates GLP-1 receptors in a way that mimics some of the effects of your body’s natural GLP-1 hormone.
Examples of GLP-1 medications include semaglutide, the active ingredient in Ozempic and Wegovy, and liraglutide, the active ingredient in Saxenda and Victoza.
Some newer medications are related to GLP-1 but work through more than one hormone pathway. Tirzepatide, the active ingredient in Mounjaro and Zepbound, activates both GIP and GLP-1 receptors. That means people may talk about it alongside GLP-1 medications, but it is more specifically a dual GIP and GLP-1 receptor agonist.
The exact medication, dose, timing, and expected effects depend on your prescription and your health history. Your prescriber is the right person to answer medication-specific questions.
Why do GLP-1 medications last longer than natural GLP-1?
Your body’s natural GLP-1 does not last very long. It is released after eating and then breaks down quickly.
GLP-1 medications are designed to last longer in the body. That longer action is part of why many people notice effects between meals, not just right after eating.
This is also why the adjustment period can feel significant. Appetite, fullness, digestion, and food tolerance may all shift as your body responds to the medication.
Why the first few months can feel confusing
The first few months on a GLP-1 medication can bring a lot of change at once.
Your appetite may change before your routines do. Your old portion sizes may stop making sense. Foods that used to feel normal may feel too heavy. You may need more planning around protein, hydration, fiber, constipation, nausea, or meal timing.
That can make the process feel more emotional than expected. Not because you are doing anything wrong, but because your body’s cues may be changing faster than your habits.
Understanding the biology can help. When you know that GLP-1 affects fullness, digestion, appetite signals, insulin, and glucagon, the experience can feel less mysterious.
What GLP-1 does not do
GLP-1 medications can be powerful tools, but they do not make the entire journey automatic.
They do not tell you what to eat when nothing sounds good.
They do not make hydration happen on its own.
They do not prevent every side effect.
They do not replace your healthcare provider.
They do not mean every symptom should be ignored as “normal.”
This is why support matters. The medication may change your biology, but you still need practical ways to respond to those changes in daily life.
Where Glo fits in
Glo was built for the in-between moments of the GLP-1 journey.
The moment when you are not sure whether a meal was too big or too heavy.
The moment when your appetite is low and you are trying to figure out what feels manageable.
The moment when you want to track water, meals, steps, side effects, or patterns without turning your whole day into a spreadsheet.
The moment when you have a question at night and do not want to fall into a forum rabbit hole.
Glo does not replace your healthcare provider. It does not diagnose, prescribe, or make medical decisions. Instead, Glo helps you understand what you are experiencing in plain language, notice patterns, build supportive habits, and feel more prepared for the journey.
GLP-1 helps your biology. Glo helps you navigate the day-to-day.
The bottom line
GLP-1 is a hormone your body already makes after eating. It helps regulate insulin, glucagon, digestion, appetite, and fullness.
GLP-1 medications are designed to activate that same system in a longer-lasting way. That is why they can affect how hungry you feel, how quickly you get full, how your stomach feels after meals, and how your body manages blood sugar.
If you are new to GLP-1 medication, these changes can feel surprising. But they are not random. They are connected to the way the medication works in the body.
And when you understand what is happening, the journey can feel a little less confusing and a lot more manageable.
References
- Holst, J.J. (2007). The Physiology of Glucagon-like Peptide 1. Physiological Reviews, American Physiological Society.
- Marathe, C.S., Rayner, C.K., Jones, K.L., & Horowitz, M. (2011). Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function. Experimental Diabetes Research.
- National Institute of Diabetes and Digestive and Kidney Diseases. What’s New in Medications for Weight Management for People with Diabetes.
- Maselli, D.B., & Camilleri, M. (2021). Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity. Advances in Therapy.
- U.S. Food and Drug Administration prescribing information for relevant GLP-1 and GLP-1-related medications, including semaglutide and tirzepatide products.
Category